Advertisement

International Journal of Clinical Pharmacy

, Volume 37, Issue 1, pp 8–11 | Cite as

An audit of the pharmacological management of ischaemic stroke patients in a metropolitan Australian hospital

  • Viviane KhalilEmail author
  • Matthew Li
  • Qiantong Amanda Hua
Short Research Report

Abstract

Background According to the Australian Bureau of Statistics, stroke is the second leading cause of death in Australia. The clinical Guidelines for stroke management published by the National Stroke Foundation provide a series of evidence based recommendations to assist clinicians in the management of stroke patients. Appropriate management of patients admitted to stroke units reduces death and disability by 20 %. Moreover, a multidisciplinary team approach also improves patient outcomes. Objective To retrospectively review the pharmacological management of ischaemic stroke patients in a metropolitan Australian hospital, and to compare adherence with the guidelines for stroke management with the national stroke foundation data with and without pharmacist intervention. Method A retrospective audit of medical records was undertaken of all patients admitted to a large teaching hospital with the diagnosis of stroke or cerebral infarction from January 2013 to May 2013. Results A total of 124 patients were included in the study. Most patients were discharged on appropriate pharmacological intervention for the prevention of secondary stroke: antihypertensive agents (71 %), lipid lowering agents (67 %) and antithrombotic (85 %) medications. Conclusion The majority of the cohort was discharged on the appropriate evidence based medications for the management of secondary stroke. Further improvement may be achieved by pharmacist intervening as part of a multidisciplinary team.

Keywords

Audit Australia Hospital pharmacist Medications Secondary stroke prevention 

Notes

Acknowledgments

The authors would like to thank Nadera Rahmani for assisting with data collection.

Funding

This study was not funded by any grants.

Conflicts of interest

None.

References

  1. 1.
    Australian Bureau of Statistics. Causes of death, Australia, 2012. Canberra (AU); 2012. ABS Cat. No. 3303.0.Google Scholar
  2. 2.
    Deloitte Access Economics. The economic impact of stroke in Australia. (Internet). Canberra: National Stroke Foundation; 2013. http://strokefoundation.com.au/site/media/Final-Deloitte-Stroke-Report-14-Mar-13.pdf.
  3. 3.
    Thrift AG, Dewey HM, Macdonell RAL, McNeil JJ, Donnan GA. Stroke incidence on the east coast of Australia: the north east Melbourne stroke incidence study (NEMESIS). Stroke. 2000;31(9):2087–92.PubMedCrossRefGoogle Scholar
  4. 4.
    Stroke Unit Trialists’ Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2007; Issue 4: CD000197.Google Scholar
  5. 5.
    National Stroke Foundation. Clinical guidelines for stroke management 2010. (Internet). Melbourne (AU): S; 2010 (Cited 31 Mar 2014). 172p. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp126.pdf ISBN 978-0-9805933-3-4.
  6. 6.
    Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev. 2009a; Issue 4: CD000213.Google Scholar
  7. 7.
    National Stroke Foundation. Clinical audit report 2013. Melbourne (AU): Stroke Foundation. ISBN 987-0-9872830-7-8. http://strokefoundation.com.au/site/media/NSF687.ClinicalServicesAudit2013.Final_.pdf.
  8. 8.
    Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis. Int Arch Med. 2009;2(1):30.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Rhoney DH. Contemporary management of transient ischaemic attack: role of the pharmacist. Pharmacotherapy. 2011;31(2):193–213.PubMedCrossRefGoogle Scholar
  10. 10.
    Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J clin Pharm. 2012;34:828–31.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Viviane Khalil
    • 1
    • 2
    Email author
  • Matthew Li
    • 1
  • Qiantong Amanda Hua
    • 1
  1. 1.Peninsula Health, Frankston Hospital, Pharmacy DepartmentMelbourneAustralia
  2. 2.University of South AustraliaAdelaideAustralia

Personalised recommendations